Wells Fargo & Company Xencor Inc Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

A detailed history of Wells Fargo & Company transactions in Xencor Inc stock. As of the latest transaction made, Wells Fargo & Company holds 36,086 shares of XNCR stock, worth $588,562. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,086
Previous 23,942 50.72%
Holding current value
$588,562
Previous $481,000 72.35%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$19.43 - $26.84 $235,957 - $325,944
12,144 Added 50.72%
36,086 $829,000
Q3 2024

Nov 13, 2024
SELL
$15.7 - $21.65 $1,946 - $2,684
-124 Reduced 0.52%
23,942 $481,000
Q2 2024

Aug 13, 2024
BUY
$18.21 - $24.5 $81,781 - $110,029
4,491 Added 22.94%
24,066 $455,000
Q1 2024

May 10, 2024
BUY
$18.65 - $26.52 $36,218 - $51,501
1,942 Added 11.01%
19,575 $433,000
Q4 2023

Feb 09, 2024
SELL
$16.53 - $21.42 $273,951 - $354,993
-16,573 Reduced 48.45%
17,633 $374,000
Q3 2023

Nov 13, 2023
SELL
$20.08 - $25.39 $275,357 - $348,173
-13,713 Reduced 28.62%
34,206 $689,000
Q2 2023

Aug 15, 2023
BUY
$24.77 - $29.9 $292,335 - $352,879
11,802 Added 32.68%
47,919 $1.2 Million
Q1 2023

May 12, 2023
BUY
$25.95 - $36.95 $852,120 - $1.21 Million
32,837 Added 1001.13%
36,117 $1.01 Million
Q4 2022

Feb 13, 2023
SELL
$24.79 - $30.86 $59,272 - $73,786
-2,391 Reduced 42.16%
3,280 $85,000
Q3 2022

Nov 14, 2022
SELL
$24.62 - $32.44 $46,630 - $61,441
-1,894 Reduced 25.04%
5,671 $148,000
Q2 2022

Aug 12, 2022
SELL
$19.74 - $29.01 $989,862 - $1.45 Million
-50,145 Reduced 86.89%
7,565 $208,000
Q1 2022

May 16, 2022
SELL
$26.68 - $41.63 $455,480 - $710,707
-17,072 Reduced 22.83%
57,710 $1.54 Million
Q4 2021

Feb 14, 2022
SELL
$33.67 - $43.44 $577,541 - $745,126
-17,153 Reduced 18.66%
74,782 $3 Million
Q3 2021

Nov 15, 2021
BUY
$30.65 - $35.68 $43,032 - $50,094
1,404 Added 1.55%
91,935 $3 Million
Q2 2021

Aug 16, 2021
BUY
$34.33 - $44.68 $226,028 - $294,173
6,584 Added 7.84%
90,531 $3.12 Million
Q1 2021

May 13, 2021
SELL
$40.81 - $53.88 $1.38 Million - $1.82 Million
-33,710 Reduced 28.65%
83,947 $3.62 Million
Q4 2020

Feb 09, 2021
BUY
$36.63 - $47.63 $142,087 - $184,756
3,879 Added 3.41%
117,657 $5.13 Million
Q3 2020

Nov 05, 2020
SELL
$30.09 - $43.02 $148,524 - $212,346
-4,936 Reduced 4.16%
113,778 $4.41 Million
Q2 2020

Aug 13, 2020
BUY
$27.76 - $33.42 $421,063 - $506,914
15,168 Added 14.65%
118,714 $3.85 Million
Q1 2020

May 14, 2020
BUY
$20.69 - $37.79 $2.14 Million - $3.91 Million
103,546 New
103,546 $3.09 Million

Others Institutions Holding XNCR

# of Institutions
198
Shares Held
73.7M
Call Options Held
1.7K
Put Options Held
4.2K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $974M
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email